BPIQ Blog

$XBI $89.00 | +8.67% Covid Updates $TFFP TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of...

$XBI $85.10 | -4.04% Covid Updates $NVAX -7.4% Novavax Announces Shipments of its COVID-19 Vaccine to European Union Member States....

$XBI $88.68 | -0.79% Covid Updates $SRNE -2.5% Sorrento Announces COVISHIELD (STI-9167) Antibody Strongly Neutralizes BA.2 Omicron...

$XBI $89.39 | -1.35% Pipeline Updates $CDAK -5.0% Data from Codiak’s exoASO™-STAT6 Preclinical Development Program for the Treatment of...

$XBI $90.61 | -4.3% Covid Updates $NVAX -3.6% Health Canada Authorizes Novavax COVID-19 Vaccine source Pipeline Updates $AGIO -5.2%...

$XBI $94.65 | -1.04% Covid Updates $ENTA -2.1% Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-235, its...

$XBI $95.64 | +4.2% Covid Updates $BNTX +5.8% BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference...

$XBI $91.81 | -1.7% Covid Updates $NVAX -11.4% Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland....

$XBI $93.35 | 1% Covid Updates $GILD Phase 2/3 Interim Data Evaluating the Safety, Tolerability and Clinical Outcomes of Veklury®...

$XBI $97.26 | +4.65% Covid Updates $IGMS +9.4% IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment...

$XBI $92.94 | -0.33% Covid Updates $NVAX -12.0% Novavax falls short of COVID-19 vaccine deliveries - Reuters. source $IMNM -4.3%...

$XBI $93.25 | +2.8% Covid Updates $RDHL -5.5% RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and...

$XBI $90.79 | +1.5% Covid Updates $NVAX +1.0% - New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine. source...

$XBI $89.44 | -2.62% Covid Updates $NVAX -1.1% Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing...

$XBI $91.85 | -3.3% Covid Updates $AVIR -3.7% Atea Pharmaceuticals Announces Publication of Data Supporting Bemnifosbuvir’s (AT-527)...

$XBI $94.94 | +1.62% Covid Updates $PFE +0.7% & $BNTX +4.4% Pfizer and BioNTech Initiate Rolling Submission for Emergency Use...

$XBI $93.43 | +5.48% Covid Updates $MRNA +6.2% Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax source $NVAX +13.0%...

$XBI $88.58 | +3.59% Covid Updates $SRNE +2.8% Sorrento Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly...

$XBI $85.51 | -4.55% Covid Updates $TFFP -8.5% TFF Pharmaceuticals Completes Enrollment in Phase 1 Study Evaluating Inhaled Formulation...

$XBI $89.59 | -1.96% Covid Updates $MRNA +1.6% Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster...